River Stone Biotech ApS: Financial statements 2021
CVR: 39126729
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
River Stone Biotech ApS (CVR 39126729) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 7,577,381 and a net result of DKK -18,792,979 compared with DKK -16,064,190 the year before. That is an increase of 205.9% compared with the year before. Equity in the 2021 report amounted to DKK -9,844,634. The company had 18 employees in the financial year.
- Gross Profit
- DKK 7,577,381
- Profit/Loss
- DKK -18,792,979
- Equity
- DKK -9,844,634
- Total Assets
- DKK 18,627,542
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 7.6 mio. | -18.8 mio. | -9.8 mio. | 18 |
| 2020 | - | 2.5 mio. | -16.1 mio. | 8.9 mio. | 15 |
| 2019 | - | 692 t. | -14.3 mio. | 10.1 mio. | 13 |
| 2018 | - | - | -11.1 mio. | -11.1 mio. | 11 |
Official annual report
Find more companies like River Stone Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
River Stone Biotech ApS has published its annual report for 2020. Gross profit came to DKK 2,476,810, and the net result was DKK -16,064,190.
About River Stone Biotech ApS
River Stone Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jørgen Hansen. The board consists of Jørgen Hansen and Paul D. Goldenheim. The company is owned by River Stone Biotech Inc.. The company has 32 employees (2026). In 2025, the company reported a gross profit of DKK 1,169,131 and a net result of DKK -31,204,765 compared with DKK -44,572,973 the year before. Equity in the 2025 report amounted to DKK 7,827,761.